| Financial Year |
September 30 2020 |
| Monetary Funds |
5,594,143,478.04 |
| Held-for-trading Financial Assets |
10,113,903,939.17 |
| Notes Receivable |
4,549,252.07 |
| Accounts Receivable |
4,404,243,225.43 |
| Advances to Suppliers |
201,461,808.20 |
| Other Receivables |
474,703,374.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
34,575,502.58 |
| Dividend Receivable |
-- |
| Inventories |
1,066,896,386.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
161,134,537.88 |
| Other Current Assets |
3,513,224,719.25 |
| Total Current Assets |
26,877,326,078.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
135,287,625.36 |
| Long-term Equity Investment |
67,260,400.02 |
| Investment Properties |
17,207,529.06 |
| Fixed Assetes |
855,255,773.38 |
| Under-construction Projects |
26,450,964.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
393,183,380.38 |
| R&D expenses |
75,325,834.15 |
| Goodwill |
201,063,029.31 |
| Long-Term Deferred and Prepaid Expenses |
12,244,270.83 |
| Deferred Income Tax Assets |
361,345,243.03 |
| Other Non-Current Assets |
138,541,934.20 |
| Sub-Total of Non-Current Assets |
13,936,013,067.60 |
| Total Assets |
40,813,339,146.43 |
| Short-Term Loans |
1,180,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
679,161,365.30 |
| Accounts Payable |
3,172,007,855.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
175,879,781.07 |
| Taxes Payable |
379,769,339.28 |
| Interest Payable |
10,743,153.31 |
| Dividend Payable |
139,122,128.37 |
| Other payables |
1,405,002,074.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
150,000,000.00 |
| Other Current Liabilities |
1,362,078,349.56 |
| Sub-Total of Current Liabilities |
20,282,999,369.63 |
| Long-term Loans |
-- |
| Bonds Payable |
503,652,000.00 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
127,724,462.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
639,612,285.68 |
| Total Liabilities |
20,922,611,655.31 |
| Paid-In Capital(Or Share Stock) |
5,718,435,744.00 |
| Capital Surplus |
4,497,669,845.95 |
| Surplus Reserve |
886,968,903.22 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,287,560,433.68 |
| Minority Stockholder's Interest |
2,959,791,644.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
16,930,935,847.11 |
| Owner's Equity（Stockholder's Equity） |
19,890,727,491.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
40,813,339,146.43 |
